From: Phenotypic alteration of macrophages during osteoarthritis: a systematic review
Author | Category | Intervention | Detected marker | Interventional site |
---|---|---|---|---|
Jablonski et al. [31] | Endogenous molecule | Cartilage regeneration model; Cartilage regeneration model in CCR2−/−CCL2−/− mouse | Cartilage regeneration model: M1: CD38+↑; Cartilage regeneration model in CCR2−/−CCL2−/− mouse: M2:CD206+F4/80+↑ | Joint |
Zhang et al. [37] | Mouse OA model; Rheb1 Knockout (KO) in myeloid cells | Mouse OA model: M0: F4/80↑; M1: iNOS↑; Mouse OA model in Rheb1 KO mouse: M0: (F4/80↑)↓; M1: (iNOS↑)↓; M2: CD206↑ | Joint | |
Zhou et al. [54] | Mouse OA model; Modified ZIF-8 Nanoparticles | Mouse OA model: CD16/32↑; Nanoparticles on OA model: (CD16/32↑) ↓, CD163↑ | Joint | |
Nobuaki et al. [52] | Mouse OA model; SRT2104 (SIRT1 activator) | SRT2104 on OA model: M1: iNOS↓; M2: CD206↑ | Joint | |
Siebelt et al. [42] | Anti-inflammation | Triamcinolone acetonide (TA) | TA: M2: CD163↑ | Joint |
Zhang et al. [45] | MSC-related option | Exosomes | Rat OA model: M1: CD86↑; M2: CD163↓; Exosome + Rat OA model: (M1: CD86↑) ↓; (M2: CD163↓) ↑ | Joint |
Shu et al. [55] | Mouse OA model; Bone marrow stem cell (BMSC) | Hyaluronan:M2c (F4/80+CD206+CD301+)↑ | Joint | |
Zhou et al. [30] | Traditional Chinese herb | Kinsenoside (Kin) | Mouse OA model: M1: CD16/32 + ↑; Kin+ Mouse OA model: (M1: CD16/32 + ↑) ↓; M2: CD206↑ | Joint |
Hu et al. [46] | Quercetin | Quercetin: M2: Arg1↑, MR↑, Ym1↑; Rat OA model: M0: CD68↑; M2: MR↑; Quercetin+ Rat OA model: (M0: CD68↑) ↓; (M2: MR↑) ↑ | Joint | |
Dai et al. [47] | Squid type II collagen (SCII) | SCII: M2: Arg1↑, Ym1↑, MR↑, Fizz1↑; Rat OA model: M0: CD68↑; M2: MR↑; SCII+ Rat OA model: M0:(CD68↑) ↓; M2: (MR↑)↑ | Joint | |
Wang et al. [35] | Others | Mouse OA model Bortezomib (BTZ) | Mouse OA model: M1: F4/80+CD86+CD63−↑; M2: F4/80+CD86−CD63+↓; BTZ+ Mouse OA model: M1: (F4/80+CD86+CD63−↑) ↓; M2: (F4/80+CD86−CD63+↓) ↑ | Joint |